Latitudinal variation in the prevalence of multiple sclerosis in Ireland, an effect of genetic diversity

McGuigan C; McCarthy A; Quigley C; Bannan L; Hawkins S A; Hutchinson M; McGuigan, C; McCarthy, A; Quigley, C; Bannan, L; Hawkins, S A; Hutchinson, M
April 2004
Journal of Neurology, Neurosurgery & Psychiatry;Apr2004, Vol. 75 Issue 4, p572
Academic Journal
journal article
Background: Northern Ireland has a high and rising prevalence rate of multiple sclerosis (MS). The most recent survey in 1996 found a rate of 168.7/100 000. Recorded prevalence rates for the south of Ireland, including County Wexford, have been markedly lower and seemed to suggest the existence of a prevalence gradient within the island.Objectives: To compare the prevalence of multiple sclerosis in Co. Wexford in the south east of Ireland and Co. Donegal in the north west, and to establish whether a variation in prevalence of MS exists within Ireland.Methods: Patients were referred from multiple sources. Review of clinical case records and/or patient examination confirmed the diagnosis.Results: In Co. Wexford, 126 patients were found to have clinically definite or probable multiple sclerosis with a prevalence rate of 120.7/100 000 (95% confidence intervals (CI) 100.6 to 143.8), which is similar to other areas of similar latitude within the British Isles. In Co. Donegal, 240 people had clinically definite or probable MS with a prevalence rate of 184.6/100 000 (95% CI 162.0 to 209.5). The difference in prevalence rates is statistically significant (Z = 3.94, p = <0.001).Conclusion: There is a latitudinal variation in the prevalence rate of MS between the north and the south of Ireland. The increased prevalence of MS seen in Co. Wexford is likely to represent better case ascertainment and improved diagnostic accuracy rather than an actual increase in prevalence. The north/south variation in prevalence may represent a variation in the genetic predisposition to MS between the background populations of the two counties.


Related Articles

  • Cognitive patterns and progression in multiple sclerosis: construction and validation of percentile curves. Achiron, A.; Polliack, M.; Roo, S. M.; Barak, Y.; Lavie, M.; Appelboim, N.; Harel, Y.; Rao, S M // Journal of Neurology, Neurosurgery & Psychiatry;May2005, Vol. 76 Issue 5, p744 

    Background and Objectives: Rate and pattern of progression of cognitive decline in multiple sclerosis (MS) has not been clearly identified. The present study aimed to identify correlations between cognitive tests and disease duration, construct longitudinal cognitive curves, and...

  • 00Clinical characteristics of multiple sclerosis in Västerbotten Country in northern Sweden. Sundström, P.; Svenningsson, A.; Nyström, L.; Forsgren, L. // Journal of Neurology, Neurosurgery & Psychiatry;May2004, Vol. 75 Issue 5, p711 

    Background: Most clinical data for multiple sclerosis are hospital based-that is, derived from patients referred to clinics specialising in the disease. Objectives: To present data derived from two population based multiple sclerosis populations, an incidence cohort and a prevalence population,...

  • Psychometric evaluation of the multiple sclerosis impact scale (MSIS-29) for proxy use. F. A. H. van der Linden; Kragt, J. J.; Klein, M.; van der Ploeg, H. M.; Polman, C. H.; Uitdehaag, B. M. J. // Journal of Neurology, Neurosurgery & Psychiatry;Dec2005, Vol. 76 Issue 12, p1677 

    Background: There may be difficulties in the use of self report measurements in patients with cognitive impairment or serious mood disturbances which interfere with reliable self assessment, as may be the case in multiple sclerosis (MS}. In such cases proxies may provide valuable information....

  • Normal-appearing grey and white matter T1 abnormality in early relapsing remitting multiple sclerosis: a longitudinal study. Davies, G. R.; Hadjiprocopis, A.; Altmann, D. R.; Chard, D. T.; Griffin, C. M.; Rashid, W.; Parker, G. J.; Tofts, P. S.; Kapoor, R.; Thompson, A. J.; Miller, D. H. // Multiple Sclerosis (13524585);Mar2007, Vol. 13 Issue 2, p169 

    Objective To investigate the presence and evolution of T1 relaxation time abnormalities in normal-appearing white matter (NAWM) and grey matter (GM), early in the course of relapsing-remitting multiple sclerosis (MS). Methods Twenty-three patients with early relapsing-remitting MS and 14 healthy...

  • Influence of HLA on progression of optic neuritis to multiple sclerosis: results of a four-year follow-up study. Kheradvar, Arash; Tabassi, Abdol Reza; Nikbin, Behrouz; Khosravi, Farideh; Naroueynejad, Mehrnaz; Moradi, Batool; Amirzargar, Ali Akbar // Multiple Sclerosis (13524585);Oct2004, Vol. 10 Issue 5, p526 

    Background: Genetic predisposition in multiple sclerosis (MS) has always been a critical concern in aetiology and progress of the disease. The present study looks into the relations between human leukocyte antigen (HLA), optic neuritis (ON) and MS in the Iranian population. Methods: Patients...

  • About redefining my fight against MS. SHRANK, DIANE // Inside MS;Winter99, Vol. 17 Issue 1, p48 

    Discusses the strategies of the author in fighting multiple sclerosis (MS). Physiological effects of MS that the author had suffered; Importance of optimizing one's health; Lessons learned by the author.

  • Readers Write.  // Inside MS;Fall2001, Vol. 19 Issue 4, p16 

    Reveals experiences of some multiple sclerosis sufferers.

  • Fund created to aid poor in financing MRI and other MS diagnostic tests.  // Fairfield County Business Journal;8/21/95, Vol. 34 Issue 34, p10 

    Reports that the Multiple Sclerosis Association of America (MSAA) is sponsoring a program called MS Diagnostic Fund designed to help people suspected of having multiple sclerosis receive proper and accurate diagnosis. Payment for the expense of a magnetic resonance imaging (MRI) exam for the...

  • Cover page.  // Healing Muse;Fall2012, Vol. 12 Issue 1, preceding p1 

    A drawing of a multiple sclerosis patient is presented.


Read the Article


Sign out of this library

Other Topics